Skip to main content
SpringerLink
Log in

Inhibition of cysteinyl-leukotriene production by azelastine and its biological significance

  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Azelastine is a phthalazinone derivative with a wide spectrum of pharmacological activities. Actively sensitized guinea pigs were used to examine the broncholytic effect of azelastinein vivo. Furthermore, the influence of azelastine on the production of arachidonic acid (AA) metabolites was investigatedin vitro and compared to the effects of nordihydroguaiaretic acid (NDGA), indomethacin and ketotifen.In vivo, azelastine protected actively sensitized guinea-pigs against ovalbumin-induced bronchospasm with an ID50 of 0.08 mg/kg orally. Ketotifen was similarly active (ID50=0.05 mg/kg). Antigen-induced contraction of isolated tracheal rings of sensitized guinea-pigs was concentration-dependently inhibited by azelastine and NDGA with IC50-values of 94.1 and 34.2 μmol/l, respectively. Ketotifen exerted only weak inhibitory activity (18% at 100 μmol/l). The arachidonic acid-induced contraction of isolated guinea-pig tracheal rings was also inhibited both by azelastine (IC50=92.6 μmol/l) and NDGA (IC50=20.4 μmol/l). Ketotifen was inactive on this model. Antigen challenge of chopped lung tissue from sensitized guinea-pigs resulted in the release of cysteinyl-leukotrienes (LT) which were identified by reversed phase high pressure liquid chromatography (HPLC) as LTD4 and LTE4. The release of cysteinyl-LT from sensitized guinea-pig lung tissue induced by antigen challenge was concentration-dependently inhibited by azelastine (IC50=35.2 μmol/l) and NDGA (IC50=8.4 μmol/l) but not by ketotifen and indomethacin. By contrast, indomethacin caused a pronounced augmentation of cysteinyl-LT release. The concentration of indomethacin, which augmented cysteinyl-LT release by 50% was 0.19 μmol/l. At the same concentration, indomethacin inhibited the release of 6-keto-PGF1α and TXB2 by about 50%. Azelastine negligible influenced 6-keto-PGF1α and slightly diminished TXB2 release from the chopped lung tissue after challenge. Its IC50-values were >2 mmol/l and 443 μmol/l, respectively. NDGA inhibited the release of 6-keto-PGF1α and TXB2 with IC50-values of 47.3 and 38.3 μmol/l, respectively. Ketotifen was ineffective in inhibiting the release of cyclo-oxygenase products of AA metabolism. It seems likely that inhibition of release of 5-lipoxygenase-derived products of AA metabolism by azelastine contributes to its antiallergic and antiasthmatic activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. C. A. Gould, S. Ollier and R. J. Davies,The effect of single and multiple dose therapy with azelastine on the immediate asthmatic response to allergen provocation testing (abstr.), Ann. Allergy55, 232 (1985).

    Google Scholar 

  2. W. Storms, E. Middleton, D. Dvorin, J. Kemp, S. Spector, J. Newton and J. L. Perhach,Azelastine (AZEL) in the treatment of asthma (abstr.), J. Allergy Clin. Immunol.75, 167 (1985).

    Article  Google Scholar 

  3. N. Chand, W. Diamantis and R. D. Sofia,Antagonism of histamine and leukotrienes by azelastine in isolated guinea-pig ileum, Agents and Actions19, 164–168 (1986).

    Article  PubMed  Google Scholar 

  4. H. J. Zechel, N. Brock, D. Lenke and U. Achterrath-Tuckermann,Pharmacological and toxicological properties of azelastine, a novel antiallergic agent, Arzn. Forsch./Drug Res.31, 1184–1193 (1981).

    Google Scholar 

  5. N. Chand, J. Pillar, W. Diamantis and R. D. Sofia,Inhibition of allergic histamine release by azelastine and selected antiallergic drugs form rabbit leukocytes, Int. Archs. Allergy Appl. Immunol.77, 451–455 (1985).

    Google Scholar 

  6. U. Achterrath-Tuckermann, C.-H. Weischer and I. Szelenyi,Azelastine, a new antiallergic/antiasthmatic agent, inhibits PAF-induced platelet aggregation, paw edema and bronchoconstriction, Pharmacology, in press (1987).

  7. B. Samuelsson,Leukotrienes: mediators of immediate hypersensitivity and inflammation, Science220, 568–575 (1983).

    PubMed  Google Scholar 

  8. N. Chand, K. Nolan, W. Diamantis, J. L. Perhach jr. and R. D. Sofia,Inhibition of leukotriene (SRS-A)-mediated allergic bronchospasm by azelastine, a novel orally effective antiasthmatic drug (abstr.), J. Allergy. Clin. Immunol.71, 149 (1983).

    Google Scholar 

  9. N. Chand, J. E. Harrison, S. M. Rooney, R. D. Sofia and W. Diamantis,Inhibition of passive cutaneous anaphylaxis (PCA) by azelastine: dissociation of its antiallergic activities from antihistaminic and antiserotonin properties, Int. J. Immunopharmacol.7, 833–838 (1985).

    Article  PubMed  Google Scholar 

  10. P. Anderson,Antigen-induced bronchial anaphylaxis in actively sensitized guinea-pigs. Pattern of response in relation to immunization regimen, Allergy35, 65–71 (1980).

    PubMed  Google Scholar 

  11. H. Konzett and R. Rössler,Versuchsanordnung zur Untersuchung an der Bronchialmuskulatur, Arch. Exp. Pathol. Pharmakol.195, 71–74 (1940).

    Article  Google Scholar 

  12. Th. Simmet, J. Aissa, D. Sutter, H. Juan and B. A. Peskar,Modulation of the contractile activity of the guinea-pig lung parenchymal strips by exogenous 5,8,11,14,17-eicosapentaenoic acid, Naunyn-Schmiedeberg's Arch. Pharmacol.335, 652–659 (1987).

    Article  Google Scholar 

  13. N. Chand, K. Nolan, W. Diamantis, J. L. Perhach and R. D. Sofia,Inhibition of leukotriene (SRS-A)-mediated acute lung anaphylaxis by azelastine in guinea pigs, Allergy41, 473–478 (1986).

    PubMed  Google Scholar 

  14. R. D. R. Camp, A. A. Coutts, M. W. Greaves, A. B. Kay and M. J. Walport,Responses of human skin to intradermal injections of leukotrienes C 4,D 4 and B 4, Br. J. Pharmac.80, 497–502 (1983).

    Google Scholar 

  15. Z. Maron, J. H. Shelhamer, M. K. Bach, D. R. Morton and M. Kaliner,Slow reacting substances, leukotriene C 4 and D 4 increase the release of mucus from human airways in vitro, Am. Rev. Resp. Dis.126, 449–451 (1982).

    PubMed  Google Scholar 

  16. A. C. Peatfield, P. J. Piper and P. S. Richardson,The effect of leukotriene C 4 on mucin release into the cat trachea in vivo and in vitro, Br. J. Pharmac.77, 391–393 (1982).

    Google Scholar 

  17. J. Nowak,Eicosanoids and the lungs, Ann. Clin. Res.16, 269–286 (1984).

    PubMed  Google Scholar 

  18. J. F. Burka,Effect of indomethacin on airway contraction and the release of LTC 4-like material, Prostaglandins29, 529–535 (1985).

    Article  PubMed  Google Scholar 

  19. J. F. Burka,Pharmacological modulation of responses of guinea-pig airways contracted with arachidonic acid, Br. J. Pharmac.85, 421–425 (1985).

    Google Scholar 

  20. J. F. Burka and M. H. Saad,Mediators of arachidonic acid-induced contractions of indomethacin-treated guinea-pig airways: leukotrienes C 4 and D 4, Br. J. Pharmac.81, 465–473 (1984).

    Google Scholar 

  21. A. M. Lefer, D. M. Roth, D. J. Lefer and J. B. Smith,Potentation of leukotriene formation in pulmonary and vascular tissue, Naunyn-Schmiedeberg's Arch. Pharmac.326, 186–189 (1984).

    Article  Google Scholar 

  22. A. G. Leitch, R. A. Lewis, E. J. Corey and K. F. Austen,Quantitation and characterisation of leukotriene products released following immunologic stimulation of human lung cells in vitro, Chest83, (5 Suppl), 81S-82S (1983).

    PubMed  Google Scholar 

  23. R. A. Lewis and K. F. Austen,The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology, J. Clin. Invest.73, 889–897 (1984).

    PubMed  Google Scholar 

  24. P. J. Piper,Pharmacology of leukotrienes, Br. Med. Bull.39, 255–259 (1983).

    PubMed  Google Scholar 

  25. R. Schulz and W. Seeger,Release of leukotrienes into the perfusate of calcium-ionophore stimulated rabbit lungs. Influence of 5-lipoxigenase inhibitors, Biochem. Pharmacol.35, 183–193 (1986).

    Article  PubMed  Google Scholar 

  26. J. L. Walker,The regulatory function of prostaglandins in the release of histamine and SRS-A from passively sensitised human lung tissue, In:Advances in the Biosciences, vol. 9, pp. 235–242 (Eds. S. Bergström and S. Bernhard). Pergamon Press, Oxford (1973).

    Google Scholar 

  27. J. J. Adcock, L. G. Garland, S. Moncada and J. A. Salmon,The mechanism of enhancement by fatty acid hydroperoxides of anaphylactic mediator release, Prostaglandins16, 179–187 (1978).

    Article  PubMed  Google Scholar 

  28. K. Brune, U. Aehringhaus and B. A. Peskar,Pharmacological control of leukotriene and prostaglandin production from mouse peritoneal macrophages, Agents and Actions14, 729–734 (1984).

    Article  PubMed  Google Scholar 

  29. U. Hoppe, B. A. Peskar and B. M. Peskar,Effect of indomethacin on prostaglandin and leukotriene formation in rat gastric mucosa and inflammatory exudate, Naunyn Schmiedeberg's Arch. Pharmacol.335 (Suppl), R-41 (1987).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Asta Pharma AG, 6000, Frankfurt 1, FRG

    U. Achterrath-Tuckermann & I. Szelenyi

  2. Institute of Pharmacology and Toxicology, Ruhr-University, 4630, Bochum 1, FRG

    T. Simmet, W. Luck & B. A. Peskar

Authors
  1. U. Achterrath-Tuckermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Simmet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. Luck
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. Szelenyi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. A. Peskar
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Author for correspondence.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Achterrath-Tuckermann, U., Simmet, T., Luck, W. et al. Inhibition of cysteinyl-leukotriene production by azelastine and its biological significance. Agents and Actions 24, 217–223 (1988). https://doi.org/10.1007/BF02028274

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02028274

Keywords

Search

Navigation